| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:732022 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PSMD10 mRNA | CTD | PMID:21570461 |
| 2-acetamidofluorene | increases expression | ISO | RGD:620350 | 6480464 | 2-Acetylaminofluorene results in increased expression of PSMD10 protein | CTD | PMID:16448463 |
| 2-acetamidofluorene | multiple interactions | ISO | RGD:620350 | 6480464 | RB1 protein affects the reaction [2-Acetylaminofluorene results in increased expression of PSMD10 protein] | CTD | PMID:16448463 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:732022 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of PSMD10 mRNA | CTD | PMID:18648102 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:732022 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of PSMD10 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:732022 | 6480464 | Benzo(a)pyrene results in increased expression of PSMD10 mRNA | CTD | PMID:22228805 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of PSMD10 mRNA | CTD | PMID:19549813 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of PSMD10 mRNA | CTD | PMID:20106945 |
| dibutyl phthalate | decreases expression | ISO | RGD:620350 | 6480464 | Dibutyl Phthalate results in decreased expression of PSMD10 mRNA | CTD | PMID:21266533 |
| doxorubicin | decreases response to substance | EXP | | 6480464 | PSMD10 results in decreased susceptibility to Doxorubicin | CTD | PMID:21287809 |
| phlorizin | decreases expression | ISO | RGD:732022 | 6480464 | Phlorhizin results in decreased expression of PSMD10 mRNA | CTD | PMID:22538082 |
| tamoxifen | decreases expression | ISO | RGD:732022 | 6480464 | Tamoxifen results in decreased expression of PSMD10 mRNA | CTD | PMID:17555576 |